Roflumilast 68382-0969-16

Package NDC

68382-0969-16

Manufacturer: Zydus Pharmaceuticals Usa Inc.
Dosage Form: Tablet
Route: Oral
Product Type: Human Prescription Drug
Marketing Start: October 3, 2022
Listing Expires: December 31, 2026
Application: ANDA208303

Need to source Roflumilast? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Roflumilast	500 ug/1

Drug Class

Phosphodiesterase 4 Inhibitor [EPC]Phosphodiesterase 4 Inhibitor [EPC]Phosphodiesterase 4 Inhibitors [MoA]

Selected Package

68382-0969-16Selected

90 TABLET in 1 BOTTLE (68382-969-16)

Other packages for this product(1)

68382-0969-06

30 TABLET in 1 BOTTLE (68382-969-06)

View →